Heyuan Biotechnology (Shanghai) Co., Ltd
Initial public offering and listing on the science and Innovation Board
Announcement on online issuance and subscription and winning rate
Sponsor (lead underwriter): Haitong Securities Company Limited(600837)
Co lead underwriter: Guotai Junan Securities Co.Ltd(601211)
The application of Heyuan Biotechnology (Shanghai) Co., Ltd. (hereinafter referred to as “Heyuan biotechnology”, “issuer” or “company”) for the initial public offering of RMB common shares (A shares) (hereinafter referred to as “this offering”) has been examined and approved by the stock listing committee of the science and Innovation Board of Shanghai Stock Exchange, It has been approved to register by China Securities Regulatory Commission (hereinafter referred to as “CSRC”) (zjxk [2022] No. 61). This issuance adopts directional placement to strategic investors (hereinafter referred to as “strategic placement”) Offline inquiry placement to qualified offline investors (hereinafter referred to as “offline issuance”) and online pricing issuance to social public investors holding non restricted A-Shares and non restricted depositary receipts market value in Shanghai market (hereinafter referred to as “online issuance”).
Haitong Securities Company Limited(600837) (hereinafter referred to as ” Haitong Securities Company Limited(600837) ” or “sponsor (lead underwriter)”) serves as the sponsor (lead underwriter) of this offering, and Guotai Junan Securities Co.Ltd(601211) (hereinafter referred to as ” Guotai Junan Securities Co.Ltd(601211) “) serves as the joint lead underwriter of this offering ( Haitong Securities Company Limited(600837) and Guotai Junan Securities Co.Ltd(601211) collectively referred to as “joint lead underwriters”). The issuer and the joint lead underwriters negotiated and determined that the number of shares issued this time is 100 million shares. The initial strategic placement is expected to issue 30 million shares, accounting for 30% of the total number of shares issued this time. The subscription funds promised by the strategic investors have been remitted to the bank account designated by the sponsor (lead underwriter) within the specified time. The final strategic placement of this issuance is 27315019 shares, accounting for 27.32% of the total issuance. The difference between the initial strategic placement and the final strategic placement of 2684981 shares is transferred back to the offline issuance.
After the adjustment of the strategic placement and before the launch of the online and offline call back mechanism, the number of offline shares issued was 58684981 million, accounting for 80.74% of the number issued after deducting the final strategic placement; The number of shares issued online was 14 million, accounting for 19.26% of the number issued after deducting the final strategic placement. The total quantity of final offline and online issuance is the total quantity of this issuance minus the final strategic placement quantity. The final online issuance quantity and the final offline issuance quantity will be determined according to the call back situation.
Heyuan biological initially issued 14 million A-Shares of “Heyuan biological” through the online pricing of the trading system of Shanghai Stock Exchange on March 11, 2022 (t day).
There are significant changes in the issuance process, subscription and payment of this offering. Please pay attention to it and fulfill the payment obligation on March 15, 2022 (T + 2):
1. The offline allocated investors shall, according to the announcement of offline preliminary placement results and online winning results of initial public offering of shares by Heyuan Biotechnology (Shanghai) Co., Ltd. and listing on the science and Innovation Board (hereinafter referred to as the announcement of offline preliminary placement results and online winning results), according to the finally determined issuance price and allocated quantity, Pay the new share subscription fund and the corresponding new share placement Commission in full and on time before 16:00 on March 15, 2022 (T + 2). Offline investors are allocated multiple new shares every day. Please pay for each new share separately. In the case of multiple new shares allocated on the same day, if only one total amount is remitted, the consolidated payment will lead to the failure of accounting, and the resulting consequences shall be borne by the investors themselves.
After online investors win the subscription of new shares, they shall fulfill the obligation of capital settlement according to the announcement of offline preliminary placement results and online winning results, so as to ensure that their capital account will have sufficient new share subscription funds on March 15 (T + 2) 2022. The transfer of investors’ funds shall comply with the relevant regulations of the securities company where the investors are located. The shares that offline and online investors give up to subscribe for are underwritten by the sponsor (lead underwriter).
2. In this offline offering, securities investment funds and other partial share asset management products (hereinafter referred to as “public offering products”), National Social Security Fund (hereinafter referred to as “social security fund”), basic endowment insurance fund (hereinafter referred to as “pension”) established by public offering Among the enterprise annuity fund (hereinafter referred to as “enterprise annuity fund”) established in accordance with the measures for the administration of enterprise annuity fund, insurance funds (hereinafter referred to as “insurance funds”) in accordance with the measures for the administration of the use of insurance funds and other relevant provisions, and qualified foreign institutional investors, 10% of the final allocated accounts (rounded up), It shall promise that the restricted period of the shares to be placed this time is 6 months from the date of the issuer’s initial public offering and listing. The sales restriction period will be determined by lottery after offline investors complete their payment. The lottery number in the online lower limit sale period will be allocated according to the placing object, and each placing object will be allocated a number. Once offline investors quote, they will be deemed to accept the online lower limit selling period arrangement of this offering.
3. When the total number of shares paid and subscribed by offline and online investors is less than 70% of the number of public offerings after deducting the final strategic placement, the joint lead underwriters will suspend the issuance of new shares and disclose the reasons for the suspension and subsequent arrangements.
4. If the offline investors with valid quotation fail to participate in the subscription or obtain the preliminary placement, and the offline investors fail to pay the subscription amount in full and in time, they will be deemed to have breached the contract and shall bear the liability for breach of contract. The joint lead underwriters shall report the breach to the China Securities Association for the record. If online investors fail to pay in full after winning the lottery three times in a row within 12 months, they shall not participate in the subscription of new shares, depositary receipts, convertible corporate bonds and exchangeable corporate bonds within 6 months (calculated as 180 natural days, including the next day) from the next day when CSDCC Shanghai branch receives the purchase abandonment declaration. The number of times of giving up subscription shall be calculated according to the number of times of investors actually giving up subscription of new shares, depositary receipts, convertible corporate bonds and exchangeable corporate bonds.
1、 Online subscription and initial winning rate of online issuance
According to the data provided by Shanghai Stock Exchange, the number of valid subscription households and 588087000 shares in this online offering is 5073867. The initial winning rate of online issuance was Nanjing Sciyon Wisdom Technology Group Co.Ltd(002380) 597%. The total number of allotments is 117617574, and the number range is 10000000000 – 100117617573.
2、 Implementation of callback mechanism, issuance structure and final winning rate of online issuance
According to the callback mechanism announced in the announcement of Heyuan Biotechnology (Shanghai) Co., Ltd. initial public offering and listing on the science and innovation board, since the initial effective subscription multiple of this online offering is 420063 times, more than 100 times, the issuer and the joint lead underwriter decided to start the callback mechanism to adjust the scale of offline and online issuance, 7.2685 million shares were transferred back from offline to online.
After the callback mechanism was launched, the final number of shares issued offline was 51416481, accounting for 70.74% of the number issued after deducting the final strategic placement, and the final number of shares issued online was 21268500, accounting for 29.26% of the number issued after deducting the final strategic placement. After the callback mechanism was launched, the final winning rate of online issuance was 003616551%.
3、 Online lottery
The issuer and the co lead underwriters have agreed to conduct the lottery for online subscription of this offering in Haitang hall, conference room on the fourth floor of Zijinshan Hotel, No. 778 Dongfang Road, Pudong, Shanghai on the morning of March 14 (T + 1), 2022, and will be published in Shanghai Securities News, China Securities News on March 15 (T + 2), 2022 The “Securities Times” and “Securities Daily” published the results of online lottery.
Issuer: sponsor (lead underwriter) of Heyuan Biotechnology (Shanghai) Co., Ltd.: Haitong Securities Company Limited(600837) co lead underwriter: Guotai Junan Securities Co.Ltd(601211) March 14, 2022 (seal page)
Issuer: Heyuan Biotechnology (Shanghai) Co., Ltd. (there is no text on this page, which is the seal page of the announcement of Heyuan Biotechnology (Shanghai) Co., Ltd. on initial public offering of shares and online issuance, subscription and winning rate of listing on the science and Innovation Board)
Sponsor (lead underwriter): Haitong Securities Company Limited(600837) mm / DD / yyyy (there is no text on this page, which is the seal page of the announcement on initial public offering, subscription and winning rate of Heyuan Biotechnology (Shanghai) Co., Ltd. listed on the science and Innovation Board)
Co lead underwriter: Guotai Junan Securities Co.Ltd(601211) mm / DD / yyyy
